Pacira reported $5.01M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Astellas Pharma JPY 4.12B 2.94B Mar/2024
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
J&J USD 2.12 0.17 Sep/2025
Ligand Pharmaceuticals USD 1.62M 150K Jun/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025
Zoetis USD 19M 4M Jun/2025